Novelix Pharmaceuticals Ltd.

Financial

	Novelix Pharma	Sai Swami Metals	Fortune Intl
Operational Metrics
Financials
5 yr Average ROE	-17.5 %	15.61 %	21.3 %
5yr average Equity Multiplier	1.26	37.55	1.25
5yr Average Asset Turnover Ratio	0.84	0.91	0.04
5yr Avg Net Profit Margin	-14.11 %	3.53 %	121.76 %
Price to Book	6.11	0.0	0.97
P/E	528.78	18.99	10.04
5yr Avg Cash Conversion Cycle	29.1 Days	140.51 Days	0.0
Inventory Days	34.04 Days	333.21 Days	0.0
Days Receivable	55.38 Days	39.87 Days	0.0
Days Payable	55.7 Days	445.02 Days	65.92 Days
5yr Average Interest Coverage Ratio	-17.77	5.43	-236.65
5yr Avg ROCE	-15.4 %	16.89 %	-1.85 %
5yr Avg Operating Profit Margin	-16.49 %	5.41 %	33.56 %
5 yr average Debt to Equity	0.05	9.91	0.24
5yr CAGR Net Profit	35.78 %	92.23 %	n/a
5yr Average Return on Assets	-13.36 %	5.13 %	18.82 %
Shareholdings
Promoter Holding	66.56 %	62.15 %	62.17 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-0.36 %	0.0	7.81 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0